STRIDES PHARMA SCIENCE LIMITED — Capital/Financing Update 2025

Mar 19, 2025

==> picture [96 x 40] intentionally omitted <==

March 19, 2025

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Scrip Code: STAR

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. Scrip Code: 532531

Dear Madam/ Sir,

• Ref: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)

Sub: Proposed de-merger of Identified Business of Arco Lab Private Limited (“Arco Lab”), a Wholly owned Subsidiary of the Company

Board of Directors of Strides Pharma Science Limited (Strides) and Arco Lab in their meeting held today have accorded their in-principle approval for the proposed demerger of Identified Business of Arco Lab.

Arco Lab is an innovative Global Life Sciences Capability Centre offering a wide range of services in life sciences consulting, technology, and business solutions.

It is proposed to transfer by way of demerger the Life Sciences and Digital Innovation Capabilities (“Identified Business”) of Arco Lab into a New Company (NewCo). Such NewCo shall focus on Life Sciences and Manufacturing solutions with deep domain knowledge and cutting-edge technology capabilities.

Arco Lab will incorporate the NewCo to facilitate the proposed demerger including undertaking requisite preparatory steps viz., drawing up of the scheme of arrangement, valuation of the identified business, amongst others. The proposed structure envisages the NewCo to be a WOS of Strides and there will not be any impact on Strides, financially or otherwise arising out of the proposed restructuring.

Requisite disclosures in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 shall be made upon incorporation of the NewCo by Arco Lab and in the further stages of the said Corporate Action.

Board meeting of Strides commenced at 10:00 hrs IST and ended at 11:30 hrs IST.

This is for your kind information and record purpose.

Thanks & regards,

For Strides Pharma Science Limited,

MANJULA R

Digitally signed by MANJULA R Date: 2025.03.19 11:34:49 +05'30'

Manjula Ramamurthy Company Secretary ICSI Membership No. A30515

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 corpcomm@strides.com; www.strides.com